AI CuratorAI-generated
Research summary · AI summary · not yet reviewedAnimal studyLaboratoryPublished in a peer-reviewed journal
Effects of Furapyrrodole on Motor Function in Mice with Experimental Autoimmune Encephalomyelitis
In a laboratory study, furapyrrodole treatment in mice with experimental autoimmune encephalomyelitis (EAE) significantly improved motor function and promoted recovery of motor neurons and myelination by stimulating neurogenesis and oligodendrogenesis.
- Tags
- #Neuroprotection
- Most relevant to
- —
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
- Human efficacy
- Not yet tested in people
- Mechanism
- Mitochondrial function
- Evidence strength
- Early – laboratory or animal research
- Outcome
- Not reported
Results in cells or animals often do not carry over to people with MS.
Why it matters
This research suggests a potential new avenue for enhancing recovery in neurodegenerative diseases like MS by targeting mitochondrial function, but it remains in preclinical stages.
What this does not prove
Findings are based on an animal model; applicability to humans is not established.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Laboratory
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-30
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Neuroprotection
- Biological target
- CYB5R3
- Pathway
- Not reported
- Population
- Mice with experimental autoimmune encephalomyelitis (EAE)
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- No severe adverse effects reported.
Original sources
- Primary evidenceTargeting Mitochondrial Redox Signaling Promotes Neuroregeneration and Functional Recovery in a Multiple Sclerosis Model. ↗DOI: 10.1002/advs.78560
Supporting passages (15)
study phaseThe in vivo efficacy of furapyrrodole was evaluated in mice with experimental autoimmune encephalomyelitis (EAE), a mouse model of MS.
study designTo stimulate in vivo neurogenesis and oligodendrogenesis by harnessing the untapped regenerative potential of endogenous neural progenitor cells (NPCs) that are upregulated in the CNS under disease conditions, we developed a novel compound that targets Notch signaling, a pathway known to suppress neuronal differentiation of NPCs.
subjectsThe in vivo efficacy of furapyrrodole was evaluated in mice with experimental autoimmune encephalomyelitis (EAE), a mouse model of MS.
speciesThe in vivo efficacy of furapyrrodole was evaluated in mice with experimental autoimmune encephalomyelitis (EAE), a mouse model of MS.
peer reviewedJournal Article
research categoriesNeurodegenerative diseases, including multiple sclerosis (MS), are characterized by progressive neuronal loss and limited regenerative capacity.
findingsFurapyrrodole treatment after the peak of EAE disease significantly improved motor function and promoted recovery of motor neurons and myelination by stimulating endogenous NPC-derived neurogenesis and oligodendrogenesis.
mechanismsOur study demonstrates for the first time that modulation of mitochondrial redox signaling promotes neuroregeneration and remyelination without causing severe adverse effects.
biological targetsFurapyrrodole, which was identified by screening a natural product-like synthetic chemical library, binds to and activates the mitochondrial reductase CYB5R3, which naturally downregulates Notch signaling downstream of γ-secretase.
populationThe in vivo efficacy of furapyrrodole was evaluated in mice with experimental autoimmune encephalomyelitis (EAE), a mouse model of MS.
safety signalsCollectively, these findings indicate furapyrrodole is a promising therapeutic candidate for MS by harnessing endogenously upregulated NPCs and inducing anti-inflammation.
human efficacyOur study demonstrates for the first time that modulation of mitochondrial redox signaling promotes neuroregeneration and remyelination without causing severe adverse effects.
publication datePublication date: 2026-10-30
limitationsTitle: Targeting Mitochondrial Redox Signaling Promotes Neuroregeneration and Functional Recovery in a Multiple Sclerosis Model.
peer reviewedPublication types: Journal Article
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.